• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ILD-GAP 联合 Charlson 共病指数评分(ILD-GAPC)作为间质性肺疾病患者的预后预测模型。

ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease.

机构信息

Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

出版信息

Can Respir J. 2023 Feb 8;2023:5088207. doi: 10.1155/2023/5088207. eCollection 2023.

DOI:10.1155/2023/5088207
PMID:36817552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9931459/
Abstract

BACKGROUND

The ILD-GAP scoring system has been widely used to predict the prognosis of patients with interstitial lung disease (ILD). The ability of the ILD-GAP scoring system combined with the Charlson Comorbidity Index score (CCIS) (ILD-GAPC) to predict ILD prognosis was investigated.

METHODS

In ILD patients, including idiopathic pulmonary fibrosis (IPF), idiopathic nonspecific interstitial pneumonia (iNSIP), collagen vascular disease-related interstitial pneumonia (CVD-IP), chronic hypersensitivity pneumonitis (CHP), and unclassifiable ILD (UC-ILD), treated between April 2013 and April 2017, the relationships between baseline clinical parameters, including age, sex, CCIS, ILD diagnosis, pulmonary function test results, and disease outcomes, were retrospectively assessed, and the ability to predict prognosis was compared between the ILD-GAP and ILD-GAPC models, respectively.

RESULTS

A total of 185 patients (mean age, 71.9 years), all of whom underwent pulmonary function testing, including percentage predicted diffusion capacity for carbon monoxide, were assessed. ILD diagnosis consisted of IPF in 57 cases, iNSIP and CVD-IP in 117 cases, CHP in 6 cases, and UC-ILD in 5 cases. The ILD-GAPC provided a greater area under the receiver operating characteristic curve (0.758) for predicting 3-year ILD-related events than the ILD-GAP (0.721). In addition, log-rank tests showed that the Kaplan-Meier curves differed significantly among low, middle, and high ILD-GAPC scores ( < 0.001), unlike ILD-GAP scores ( = 0.083).

CONCLUSIONS

The ILD-GAPC model could provide more accurate information for predicting prognosis in patients with ILD than the ILD-GAP model.

摘要

背景

ILD-GAP 评分系统已被广泛用于预测间质性肺疾病(ILD)患者的预后。本研究旨在探讨 ILD-GAP 评分系统联合 Charlson 合并症指数评分(CCIS)(ILD-GAPC)预测ILD 预后的能力。

方法

回顾性分析 2013 年 4 月至 2017 年 4 月间收治的特发性肺纤维化(IPF)、特发性非特异性间质性肺炎(iNSIP)、结缔组织疾病相关性间质性肺炎(CVD-IP)、慢性过敏性肺炎(CHP)和未分类间质性肺病(UC-ILD)患者的临床基线参数(年龄、性别、CCIS、ILD 诊断、肺功能检查结果和疾病结局等)与预后的关系,并分别比较 ILD-GAP 和 ILD-GAPC 模型预测预后的能力。

结果

共纳入 185 例患者(平均年龄 71.9 岁),所有患者均行肺功能检查,包括一氧化碳弥散量占预计值的百分比。ILD 诊断包括 57 例 IPF、117 例 iNSIP 和 CVD-IP、6 例 CHP 和 5 例 UC-ILD。ILD-GAPC 预测 3 年ILD 相关事件的受试者工作特征曲线下面积(AUC)大于 ILD-GAP(分别为 0.758 和 0.721)。此外,log-rank 检验显示,ILD-GAPC 评分低、中、高分组的 Kaplan-Meier 曲线差异有统计学意义(<0.001),ILD-GAP 评分差异无统计学意义(=0.083)。

结论

ILD-GAPC 模型比 ILD-GAP 模型能为预测ILD 患者的预后提供更准确的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a618/9931459/cfcaa282aa1c/CRJ2023-5088207.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a618/9931459/590002fce283/CRJ2023-5088207.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a618/9931459/241161a9f59d/CRJ2023-5088207.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a618/9931459/cfcaa282aa1c/CRJ2023-5088207.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a618/9931459/590002fce283/CRJ2023-5088207.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a618/9931459/241161a9f59d/CRJ2023-5088207.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a618/9931459/cfcaa282aa1c/CRJ2023-5088207.003.jpg

相似文献

1
ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease.ILD-GAP 联合 Charlson 共病指数评分(ILD-GAPC)作为间质性肺疾病患者的预后预测模型。
Can Respir J. 2023 Feb 8;2023:5088207. doi: 10.1155/2023/5088207. eCollection 2023.
2
ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.ILD-GAP 联合单核细胞比率可能比 ILD-GAP 更能预测间质性肺疾病患者的预后。
BMC Pulm Med. 2024 Jan 5;24(1):16. doi: 10.1186/s12890-023-02833-6.
3
Clinical utility of a composite scoring system including Charlson Comorbidity Index score in patients with interstitial lung disease.包含查尔森合并症指数评分的综合评分系统在间质性肺疾病患者中的临床应用价值。
J Thorac Dis. 2020 Oct;12(10):5774-5782. doi: 10.21037/jtd-20-1302.
4
Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.无法分类的间质性肺疾病的临床特征:与慢性纤维化性特发性间质性肺炎的比较。
J Int Med Res. 2018 Jan;46(1):448-456. doi: 10.1177/0300060517719767. Epub 2017 Jul 31.
5
A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.一项针对丹麦间质性肺疾病患者的队列研究:负担、严重程度、治疗与生存情况。
Dan Med J. 2015 Apr;62(4):B5069.
6
Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.特发性肺纤维化以外的间质性肺疾病患者急性加重后的预后。
Clin Respir J. 2021 Mar;15(3):336-344. doi: 10.1111/crj.13304. Epub 2020 Dec 10.
7
Predicting survival across chronic interstitial lung disease: the ILD-GAP model.预测慢性间质性肺病的生存情况:ILD-GAP 模型。
Chest. 2014 Apr;145(4):723-728. doi: 10.1378/chest.13-1474.
8
Prevalence and prognosis of unclassifiable interstitial lung disease.无法分类的间质性肺疾病的患病率和预后。
Eur Respir J. 2013 Sep;42(3):750-7. doi: 10.1183/09031936.00131912. Epub 2012 Dec 6.
9
Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.单中心真实世界经验:吡非尼酮治疗特发性肺纤维化和特发性非特异性间质性肺炎纤维化患者的疗效。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963015. doi: 10.1177/1753466620963015.
10
Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?风险预测模型对评估类风湿关节炎相关间质性肺疾病患者的生存率有用吗?
BMC Pulm Med. 2017 Jan 13;17(1):16. doi: 10.1186/s12890-016-0358-2.

引用本文的文献

1
Predicting Outcomes using DIGital TechnologY in patients with Interstitial Lung Disease (PRODIGY-ILD): Protocol for a Prospective Cohort Study.使用数字技术预测间质性肺疾病患者的预后(PRODIGY-ILD):一项前瞻性队列研究方案
BMJ Open. 2025 Apr 28;15(4):e088271. doi: 10.1136/bmjopen-2024-088271.
2
Developing an IPF Prognostic Model and Screening for Key Genes Based on Cold Exposure-Related Genes Using Bioinformatics Approaches.基于冷暴露相关基因,运用生物信息学方法构建特发性肺纤维化预后模型并筛选关键基因
Biomedicines. 2025 Mar 11;13(3):690. doi: 10.3390/biomedicines13030690.
3
A study to correlate the association of Gender, Age, Physiology (GAP) index and radiological patterns in interstitial lung disease.

本文引用的文献

1
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities.尼达尼布治疗老年特发性肺纤维化或合并症患者的疗效和安全性。
Respir Res. 2021 Apr 26;22(1):125. doi: 10.1186/s12931-021-01695-y.
2
Clinical utility of a composite scoring system including Charlson Comorbidity Index score in patients with interstitial lung disease.包含查尔森合并症指数评分的综合评分系统在间质性肺疾病患者中的临床应用价值。
J Thorac Dis. 2020 Oct;12(10):5774-5782. doi: 10.21037/jtd-20-1302.
3
Automated computed tomography quantification of fibrosis predicts prognosis in combined pulmonary fibrosis and emphysema in a real-world setting: a single-centre, retrospective study.
一项关于间质性肺疾病中性别、年龄、生理指标(GAP)指数与放射学模式之间相关性的研究。
J Family Med Prim Care. 2025 Jan;14(1):425-433. doi: 10.4103/jfmpc.jfmpc_1334_24. Epub 2025 Jan 13.
4
Clinical characteristics and prognosis of amyopathic dermatomyositis patients with interstitial lung disease: insights from a retrospective cohort.伴有间质性肺病的无肌病性皮肌炎患者的临床特征及预后:一项回顾性队列研究的见解
Orphanet J Rare Dis. 2025 Feb 6;20(1):53. doi: 10.1186/s13023-025-03575-w.
5
Evaluation of comorbidity burden on disease progression and mortality in patients with interstitial pneumonia with autoimmune features: A retrospective cohort study.自身免疫特征性间质性肺炎患者共病负担对疾病进展和死亡率的评估:一项回顾性队列研究
PLoS One. 2025 Feb 4;20(2):e0316762. doi: 10.1371/journal.pone.0316762. eCollection 2025.
6
Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD.流式细胞术对间质性肺疾病患者支气管肺泡灌洗淋巴细胞和中性粒细胞定量分析的预测价值
Cells. 2024 Dec 13;13(24):2066. doi: 10.3390/cells13242066.
7
Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung disease.血清血红素加氧酶-1 作为间质性肺疾病急性加重患者的预后生物标志物。
Sci Rep. 2023 Dec 19;13(1):22639. doi: 10.1038/s41598-023-49342-4.
8
Prognostic Value of Serum Biomarkers in Patients with Idiopathic Pulmonary Fibrosis in Relation to Disease Progression.血清生物标志物在特发性肺纤维化患者中与疾病进展相关的预后价值。
J Pers Med. 2023 Aug 26;13(9):1307. doi: 10.3390/jpm13091307.
自动化计算机断层扫描纤维化定量预测现实世界中合并性肺纤维化和肺气肿的预后:一项单中心、回顾性研究。
Respir Res. 2020 Oct 20;21(1):275. doi: 10.1186/s12931-020-01545-3.
4
A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future.采用治疗目标和可治疗特征的慢性气道疾病(CAD)治疗方法:展望未来。
Int J Chron Obstruct Pulmon Dis. 2020 Sep 4;15:2091-2100. doi: 10.2147/COPD.S263430. eCollection 2020.
5
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study).进行性纤维化间质性肺疾病:一项临床队列研究(PROGRESS研究)
Eur Respir J. 2021 Feb 11;57(2). doi: 10.1183/13993003.02718-2020. Print 2021 Feb.
6
Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies.进行性纤维性间质性肺病:可治疗特征和治疗策略。
Curr Opin Pulm Med. 2020 Sep;26(5):436-442. doi: 10.1097/MCP.0000000000000712.
7
MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases.微小 RNA 与活性氧在心脏和肺部疾病中的相互作用
Int J Mol Sci. 2020 Jun 19;21(12):4370. doi: 10.3390/ijms21124370.
8
Cardiovascular implications of idiopathic pulmonary fibrosis: A way forward together?特发性肺纤维化的心血管影响:携手共进的途径?
Am Heart J. 2020 Aug;226:69-74. doi: 10.1016/j.ahj.2020.04.027. Epub 2020 May 6.
9
Complications and hospital admission in the following 90 days after lung cryobiopsy performed in interstitial lung disease.间质性肺疾病行肺冷冻活检后 90 天内的并发症和住院情况。
Respir Med. 2020 Apr-May;165:105934. doi: 10.1016/j.rmed.2020.105934. Epub 2020 Mar 19.
10
Predictors of progression in systemic sclerosis patients with interstitial lung disease.系统性硬皮病合并间质性肺病患者进展的预测因素。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.02026-2019. Print 2020 May.